Seeking men and women who are within the first few hours of experiencing an ischemic stroke (caused by a blood clot blocking blood flow to the brain) for a study comparing medication combinations to reduce the impact of the stroke.
Seeking men and women who are experiencing acute ischemic strokes caused by a blood clot blocking blood flow to a major artery in their brain for a study of an investigational device to remove the blood clot.
Seeking men and women who are participating in the ARCADIA stroke prevention trial for a study of the effect of the study drugs Apixaban and Aspirin on the occurrence of silent strokes and memory loss.
Seeking men and women who are within 10 hours from the time they started to have stroke symptoms for a study of how well people who get the investigational drug in additional to the usual treatment recover compared to people who get a medicine without any active drug (placebo) in addition to the usual treatment.
Volunteers who are at risk for having heart disease, taking aspirin, and will be or have already undergone a cardiac catheterization sought for a study of how the body makes blood clots and its effect on the risk for heart attack and stroke.
This study is looking at an experimental treatment for patients diagnosed with a stroke caused by a blockage in the blood vessels within the brain.
Seeking Ischemic (caused by reduced blood flow by narrowed or blocked arteries) stroke survivors aged 45 and older for a study of an investigational therapy using anticoagulant drugs (aspirin or apixiaban) for the prevention of another stroke
People who have been or will be treated with the Embotrap II device to remove blood clots to try to restore blood flow to the brain are being asked to participate in the EXCELLENT registry. This registry will collect and analyze the blood clots removed from the brain with the Embotrap II to study the different types of clots that cause stroke.